Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Revenue (2016 - 2025)

Historic Revenue for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to $113.7 million.

  • Mimedx's Revenue rose 3529.51% to $113.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $393.4 million, marking a year-over-year increase of 1477.14%. This contributed to the annual value of $348.9 million for FY2024, which is 852.38% up from last year.
  • According to the latest figures from Q3 2025, Mimedx's Revenue is $113.7 million, which was up 3529.51% from $98.6 million recorded in Q2 2025.
  • Over the past 5 years, Mimedx's Revenue peaked at $113.7 million during Q3 2025, and registered a low of $50.8 million during Q4 2021.
  • In the last 5 years, Mimedx's Revenue had a median value of $81.3 million in 2023 and averaged $77.9 million.
  • In the last 5 years, Mimedx's Revenue crashed by 2587.24% in 2021 and then skyrocketed by 4637.0% in 2022.
  • Over the past 5 years, Mimedx's Revenue (Quarter) stood at $50.8 million in 2021, then soared by 46.37% to $74.4 million in 2022, then grew by 16.75% to $86.8 million in 2023, then rose by 7.0% to $92.9 million in 2024, then increased by 22.41% to $113.7 million in 2025.
  • Its last three reported values are $113.7 million in Q3 2025, $98.6 million for Q2 2025, and $88.2 million during Q1 2025.